293 related articles for article (PubMed ID: 21792710)
1. HLA-G regulators in cancer medicine: an outline of key requirements.
Zidi I; Ben Amor N
Tumour Biol; 2011 Dec; 32(6):1071-86. PubMed ID: 21792710
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges.
Lin A; Yan WH
Front Immunol; 2018; 9():2164. PubMed ID: 30319626
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
Xu HH; Gan J; Xu DP; Li L; Yan WH
Front Immunol; 2021; 12():614773. PubMed ID: 34276642
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
[TBL] [Abstract][Full Text] [Related]
5. HLA-G: A New Immune Checkpoint in Cancer?
Krijgsman D; Roelands J; Hendrickx W; Bedognetti D; Kuppen PJK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630545
[TBL] [Abstract][Full Text] [Related]
6. The dual role of HLA-G in cancer.
Rouas-Freiss N; Moreau P; LeMaoult J; Carosella ED
J Immunol Res; 2014; 2014():359748. PubMed ID: 24800261
[TBL] [Abstract][Full Text] [Related]
7. HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers.
Li P; Wang N; Zhang Y; Wang C; Du L
Front Immunol; 2021; 12():791535. PubMed ID: 34868081
[TBL] [Abstract][Full Text] [Related]
8. The non-classical antigens of HLA-G and HLA-E as diagnostic and prognostic biomarkers and as therapeutic targets in transplantation and tumors.
Seliger B
Clin Transpl; 2013; ():465-72. PubMed ID: 25095542
[TBL] [Abstract][Full Text] [Related]
9. TGF-β induces HLA-G expression through inhibiting miR-152 in gastric cancer cells.
Guan Z; Song B; Liu F; Sun D; Wang K; Qu H
J Biomed Sci; 2015 Dec; 22():107. PubMed ID: 26627200
[TBL] [Abstract][Full Text] [Related]
10. The immunosuppressive molecule HLA-G and its clinical implications.
González A; Rebmann V; LeMaoult J; Horn PA; Carosella ED; Alegre E
Crit Rev Clin Lab Sci; 2012; 49(3):63-84. PubMed ID: 22537084
[TBL] [Abstract][Full Text] [Related]
11. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients.
Zeestraten EC; Reimers MS; Saadatmand S; Goossens-Beumer IJ; Dekker JW; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
Br J Cancer; 2014 Jan; 110(2):459-68. PubMed ID: 24196788
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways: human leukocyte antigen G (HLA-G).
Curigliano G; Criscitiello C; Gelao L; Goldhirsch A
Clin Cancer Res; 2013 Oct; 19(20):5564-71. PubMed ID: 23897901
[TBL] [Abstract][Full Text] [Related]
13. HLA-G Neo-Expression on Tumors.
Loustau M; Anna F; Dréan R; Lecomte M; Langlade-Demoyen P; Caumartin J
Front Immunol; 2020; 11():1685. PubMed ID: 32922387
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.
Yie SM; Hu Z
Histol Histopathol; 2011 Mar; 26(3):409-20. PubMed ID: 21210353
[TBL] [Abstract][Full Text] [Related]
15. HLA-G and humanized mouse models as a novel therapeutic approach in transplantation.
Ajith A; Portik-Dobos V; Horuzsko DD; Kapoor R; Mulloy LL; Horuzsko A
Hum Immunol; 2020 Apr; 81(4):178-185. PubMed ID: 32093884
[TBL] [Abstract][Full Text] [Related]
16. Role of HLA-G in tumors and upon COVID-19 infection.
Seliger B
Hum Immunol; 2024 May; 85(3):110792. PubMed ID: 38555250
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HLA-G Regulation and HLA Expression in Breast Cancer and Malignant Melanoma Cell Lines upon IFN-γ Stimulation and Inhibition of DNA Methylation.
Jørgensen N; Sayed A; Jeppesen HB; Persson G; Weisdorf I; Funck T; Hviid TVF
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560316
[TBL] [Abstract][Full Text] [Related]
18. Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients.
Hiraoka N; Ino Y; Hori S; Yamazaki-Itoh R; Naito C; Shimasaki M; Esaki M; Nara S; Kishi Y; Shimada K; Nakamura N; Torigoe T; Heike Y
Cancer Sci; 2020 Aug; 111(8):3057-3070. PubMed ID: 32495519
[TBL] [Abstract][Full Text] [Related]
19. HLA-G as a tolerogenic molecule in transplantation and pregnancy.
Rebmann V; da Silva Nardi F; Wagner B; Horn PA
J Immunol Res; 2014; 2014():297073. PubMed ID: 25143957
[TBL] [Abstract][Full Text] [Related]
20. Expression and change of miR-199b-5p, s HLA-G in thyroid carcinoma.
Tan B; Guo J; Wang L; Wang L; Gan X; Chen B
Exp Mol Pathol; 2021 Jun; 120():104643. PubMed ID: 33932399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]